Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 43Pancreatic Neoplasms 17Stomach Neoplasms 16Rectal Neoplasms 10Neoplasms 10Neoplasm Metastasis 10Colonic Neoplasms 7Adenocarcinoma 7Carcinoma, Non-Small-Cell Lung 6Carcinoma, Hepatocellular 6Biliary Tract Neoplasms 5Gastrointestinal Neoplasms 4Esophageal Neoplasms 4Cholangiocarcinoma 4Burkitt Lymphoma 4Advanced Solid Tumors 4Adenocarcinoma Of Esophagus 4Leukemia, Biphenotypic, Acute 3Esophageal Squamous Cell Carcinoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Peritoneal Neoplasms 2Ovarian Neoplasms 2Locally Recurrent Rectal Cancer 2Gallbladder Neoplasms 2Endometrial Neoplasms 2Appendiceal Neoplasms 2Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Solid Tumors 1

Interventions

dehydroftorafur 1Taxes 1Ramucirumab 1Paclitaxel 1Leucovorin 1Irinotecan 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Metastatic Small Intestinal Adenocarcinoma × Leucovorin × Clear all
NCT04205968 2025-11-05

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

SWOG Cancer Research Network

Phase 2 Recruiting
94 enrolled

Metastatic Small Intestinal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡